当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Mohammed BR, Malang SK, Mailafia S and Agbede RIS
Biotechnology is an already established technique in several areas of medicine, but its application in the field of veterinary medicine has only started to emerge with the potential to revolutionize veterinary practice. This paper
therefore reviews the potential applications of biotechnology in veterinary medicine towards diagnosis and treatment in Africa which includes; molecular gene cloning, production of recombinant biotechnology derived vaccines, application of polymerase chain reaction (PCR), Real time polymerase chain reaction (RT-PCR), Polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) and Bioinformatics to diagnosis of infectious and parasitic diseases , gene therapy, disease diagnosis, treatment delivery systems and many more. These components occur in other parts of the world and are therefore presumed to be consolidated into the African delivery framework as a private enterprise in a foreseeable future. Whilst it is sensible to postulate that biotechnology application and its peculiar evolution will imminently transform veterinary medicine, there is immense treat, amidst stakeholders in the industry, about food health and safety and other civil and ethical concerns which can hinder this novel scientific breakthrough. The ethical concerns which include; theory of the Three Rs (Reduction of animal population, Refinement of enactments and farm managements to curtail affliction and despair, Replacement of animals with non-animal surrogate wherever necessary. Limitations regarding the application to veterinary practices are extensively discussed. This review has implication on the future of revolutionalisation of veterinary practice and increase in animal protein source for human consumption